BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26281683)

  • 1. [Development of biomarkers for molecular target drugs].
    Saijo K; Ishioka C
    Nihon Rinsho; 2015 Aug; 73(8):1308-12. PubMed ID: 26281683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
    Philip R; Carrington L; Chan M
    Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biggest challenges currently facing companion diagnostic advancement.
    Halim AB
    Expert Rev Mol Diagn; 2014 Jan; 14(1):27-35. PubMed ID: 24308333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research and development for cancer biomarker].
    Nakagawa H
    Nihon Rinsho; 2012 May; 70(5):743-7. PubMed ID: 22619995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DxS Ltd.
    Cross J
    Pharmacogenomics; 2008 Apr; 9(4):463-7. PubMed ID: 18384259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer biomarkers, companion diagnostics and personalized oncology.
    Ross JS
    Biomark Med; 2011 Jun; 5(3):277-9. PubMed ID: 21657836
    [No Abstract]   [Full Text] [Related]  

  • 11. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
    Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
    Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 13. Companion diagnostics: the key to personalized medicine. Foreword.
    Jørgensen JT
    Expert Rev Mol Diagn; 2015 Feb; 15(2):153-6. PubMed ID: 25597758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and potential clinical utility of biomarkers for HDAC inhibitors.
    Shi B; Xu W
    Drug Discov Ther; 2013 Aug; 7(4):129-36. PubMed ID: 24071574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Companion diagnostic testing for targeted cancer therapies: an overview.
    Fan YS
    Genet Test Mol Biomarkers; 2013 Jul; 17(7):515-23. PubMed ID: 23574530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 19. The folate receptor as a rational therapeutic target for personalized cancer treatment.
    Assaraf YG; Leamon CP; Reddy JA
    Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Response predictive biomarkers to targeted therapies in oncology].
    Harlé A; Merlin JL
    Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.